Donkervoort T, Sterling A, van Ness J, Donker P J
Eur Urol. 1977;3(4):218-25. doi: 10.1159/000472101.
20 patients with benign prostatic hypertrophy were admitted to a double-blind noncrossover study for evaluation of the effect of Tadenan. Using either standard clinical criteria or urodynamic data obtained by the urinary drop spectrometer, no significant effect was found for the dosage and period of administration used.
20名良性前列腺增生患者被纳入一项双盲非交叉研究,以评估他地那非的疗效。采用标准临床标准或通过尿滴光谱仪获得的尿动力学数据,未发现所用剂量和给药期有显著效果。